KPWHRI will soon enroll volunteers in a phase 3 clinical trial to evaluate a COVID-19…
emcguinnNovember 6, 2020
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at…
emcguinnNovember 5, 2020
Gene editing is often touted as a permanent method for correcting mutations, but its long-term…
emcguinnNovember 5, 2020
Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today…
emcguinnNovember 3, 2020
A major scientific effort is underway to characterize the proteins in the cerebrospinal fluid to…
emcguinnNovember 3, 2020
Dr. Anna Wald, a clinical virologist who built a career at Fred Hutchinson Cancer Research…
emcguinnNovember 2, 2020
A safe, effective, and scalable vaccine is needed to halt the ongoing SARS-CoV-2 pandemic. We…
emcguinnNovember 2, 2020
When Dr. Stephen Smith of Seattle Children’s Research Institute came down with muscle aches, gastrointestinal distress and…
emcguinnOctober 30, 2020
